Two of the Centre’s strategic priorities are to foster the development and translation of peptide and protein biomolecules and new technologies for societal benefit, and to position Australia at the international forefront of peptide and protein science. The Industry Engagement and International Connections Portfolio informs and guides the development of initiatives that enable the Centre to achieve these strategic priorities. These initiatives promote and develop deep collaboration with industry partners, enable CIPPS researchers to engage with end-users to create new platform technologies, assist progress towards translation and research impact including commercial outcomes, and facilitate collaboration with leading international peers.
Portfolio contact: Richard Kim
Industry Placement at AstraZeneca – Josh Hammond
Read Josh's experience at AstraZeneca Josh Hammond
